You are on Trendlyne United States. Click here to go to India website or make United States as your default

7.99 -0.25 (-3.03%)

32.23% Fall from 52W High

68,029 XNAS Volume

High volume today

XNAS 21 Apr, 2025 3:24 PM (EDT)

Brainsway Ltd - ADR Key Metrics

Select
All financials are in USD Million and price data in USD
VIEW MORE
High Financial Strength
55.6 / 100
Mid Valuation
39.3 / 100
Technically Neutral
41.6 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

Brainsway Ltd - ADR Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2620406080Actual RevenueAvg. Estimate
Hit

Brainsway Ltd - ADR's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

Current EPS
0.1
Avg. Estimate
0.1
Low Estimate
0.1
High Estimate
0.2
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 33.3% in FY25

Consensus Recommendation

3 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.21Buy2Strong Buy

The consensus recommendation from 3 analysts for Brainsway Ltd - ADR is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Brainsway Ltd - ADR Stock Analysis

Brainsway Ltd - ADR stock analysis with key metrics, changes, and trends.

Brainsway Ltd - ADR MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$41.02 M29.04%positive

Annual Revenue rose 29.04%, in the last year to $41.02 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$2.92 M169.6%positive

Annual Net Profit rose 169.6% in the last year to $2.92 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio51.61-negative

Price to Earning Ratio is 51.61, higher than its sector PE ratio of 29.09.

Stock Price$7.9964.07%positive

Stock Price rose 64.07% and outperformed its sector by 59.14% in the past year.

Quarterly Revenue$11.41 M26.41%positive

Quarterly Revenue rose 26.41% YoY to $11.41 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$1.55 M1118.9%positive

Quarterly Net profit rose 1,118.9% YoY to $1.55 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Return on Equity(ROE)5.62 %5.62%negative

Return on Equity(ROE) for the last financial year was 5.62%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding2.60 %0.01%positive

Mutual Fund Holding increased by 0.01% in the last quarter to 2.6.

Interest Coverage Ratio3.28-positive

Interest Coverage Ratio is 3.28, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding29.39 %0.04%positive

Institutional Holding increased by 0.04% in the last quarter to 29.39.

VIEW LESS


Loading data..

Brainsway Ltd - ADR - Company Profile

What does Brainsway Ltd - ADR do?

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Brainsway Ltd - ADR Management structure

All Gross Remunerations are in USD
Dr. Christopher Richard von Jako, PhD
President and Chief Executive Officer
867.05 K
2022
Gross Remuneration
Year
Mr. Hadar Levy
Chief Executive Officer
550.83 K
2022
Gross Remuneration
Year
Mr. R. Scott Areglado
Senior Vice President and Chief Financial Officer
506.25 K
2022
Gross Remuneration
Year
Mr. Christopher Boyer
Vice President of Global Marketing
401.54 K
2022
Gross Remuneration
Year
Mr. Amit Ginou
Vice President and and Israel Site Manager
317.15 K
2022
Gross Remuneration
Year
Dr. Yiftach Roth
Chief Scientist
-
2022
Gross Remuneration
Year

Brainsway Ltd - ADR Board of directors

All Gross Remunerations are in USD
Dr. David Zacut
Vice Chairman of the Board
106.56 K
2022
Gross Remuneration
Year
Professor Abraham Zangen
Director
77.2 K
2022
Gross Remuneration
Year
Ms. Karen Sarid
Independent Director
74.97 K
2022
Gross Remuneration
Year
Ms. Eti Mitrany
Independent Director
66.56 K
2022
Gross Remuneration
Year
Mr. Avner Lushi
Independent Director
64.32 K
2022
Gross Remuneration
Year
Mr. Yossi Ben Shalom
Independent Director
55.79 K
2022
Gross Remuneration
Year

Brainsway Ltd - ADR FAQ

How is Brainsway Ltd - ADR today?
Brainsway Ltd - ADR today is trading in the red, and is down by -3.03% at 7.99.
Brainsway Ltd - ADR is currently trading down -3.03% on an intraday basis. In the past week the stock fell -5.56%. stock has been down -21.90% in the past quarter and rose 64.07% in the past year. You can view this in the overview section.